– USA, UT – Seek Labs, a healthcare innovations company developing next-generation molecular diagnostic systems and novel CRISPR-based gene therapies, announced the appointment of Dr. Randy Rasmussen (Ph.D.), to its Board of Directors, effective March 27, 2024, bringing over three decades of experience in molecular diagnostic development and management to the company.
About Dr. Randy Rasmussen
Having amassed a remarkable track record of advancements in molecular diagnostic technologies throughout his career, Dr. Randy Rasmussen is a highly regarded figure in the field of molecular diagnostics. His extensive knowledge and background in molecular biology and Syndromic testing, coupled with a passion for patient-focused diagnostic innovation, positions Dr. Rasmussen as a valuable addition to Seek Labs as the company progresses toward product development and commercialization.
Randy Rasmussen co-founded BioFire Diagnostics (previously Idaho Technology) in 1991. Dr. Rasmussen, who went on to hold positions as President, COO, and CEO, led BioFire through countless milestones, including growing the company to over 3,000 employees, developing biothreat surveillance technologies for the US military, and inventing the field of Syndromic testing for easy diagnosis of infectious disease syndromes. Dr. Rasmussen also led BioFire through a successful $500M sale to BioMérieux and strategically supported a dual IPO/acquisition path led by JP Morgan in 2020.
Dr. Rasmussen earned a BSc in Biochemistry from Utah State University and went on to earn a PhD in Molecular Biology from the University of Utah. Dr. Rasmussen has authored or co-authored over 20 publications and has developed several patented technologies. Dr. Rasmussen currently serves as Chairman of the Board for BioUtah and as a Board Member for Quansys Biosciences.
About Seek Labs
Seek Labs is a company united by a vision to advance scientific discovery and universal solutions. Seek Labs strives to innovate healthcare solutions that bridge gaps between patients, providers, and treatments. Seek Labs is united by the passion of our founders and their shared beliefs that healthcare solutions should empower individuals and serve their specific needs. Today—after years of experimentation, failure, and breakthrough— Seek Labs is developing new solutions for point-of-care diagnostics and CRISPR-based pharmaceutical technologies that have the potential to revolutionize the detection and treatment of diseases.
Seek Labs is headquartered in Salt Lake City, Utah. Seek Labs is a proud member of the BioHive, a collective representing the life science and healthcare innovation ecosystem in Utah. BioHive is dedicated to all the ways our work can positively impact the lives of our community, our teams, and our patients.
For more information: https://seeklabs.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
